Literature DB >> 33524253

A Bifunctional NAD+ for Profiling Poly-ADP-Ribosylation-Dependent Interacting Proteins.

Albert T Lam1, Xiao-Nan Zhang1, Valentine V Courouble2, Timothy S Strutzenberg2, Hua Pei3, Bangyan L Stiles1, Stan G Louie3, Patrick R Griffin2, Yong Zhang1,4,5,6.   

Abstract

Protein poly-ADP-ribosylation (PARylation) is a heterogeneous and dynamic post-translational modification regulated by various writers, readers, and erasers. It participates in a variety of biological events and is involved in many human diseases. Currently, tools and technologies have yet to be developed for unambiguously defining readers and erasers of individual PARylated proteins or cognate PARylated proteins for known readers and erasers. Here, we report the generation of a bifunctional nicotinamide adenine dinucleotide (NAD+) characterized by diazirine-modified adenine and clickable ribose. By serving as an excellent substrate for poly-ADP-ribose polymerase 1 (PARP1)-catalyzed PARylation, the generated bifunctional NAD+ enables photo-cross-linking and enrichment of PARylation-dependent interacting proteins for proteomic identification. This bifunctional NAD+ provides an important tool for mapping cellular interaction networks centered on protein PARylation, which are essential for elucidating the roles of PARylation-based signals or activities in physiological and pathophysiological processes.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33524253      PMCID: PMC7909001          DOI: 10.1021/acschembio.0c00937

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  45 in total

1.  Iduna protects the brain from glutamate excitotoxicity and stroke by interfering with poly(ADP-ribose) polymer-induced cell death.

Authors:  Shaida A Andrabi; Ho Chul Kang; Jean-François Haince; Yun-Il Lee; Jian Zhang; Zhikai Chi; Andrew B West; Raymond C Koehler; Guy G Poirier; Ted M Dawson; Valina L Dawson
Journal:  Nat Med       Date:  2011-05-22       Impact factor: 53.440

Review 2.  New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs.

Authors:  Bryan A Gibson; W Lee Kraus
Journal:  Nat Rev Mol Cell Biol       Date:  2012-06-20       Impact factor: 94.444

3.  Poly(ADP-ribose) binds to specific domains in DNA damage checkpoint proteins.

Authors:  J M Pleschke; H E Kleczkowska; M Strohm; F R Althaus
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

4.  Identifying Family-Member-Specific Targets of Mono-ARTDs by Using a Chemical Genetics Approach.

Authors:  Ian Carter-O'Connell; Haihong Jin; Rory K Morgan; Roko Zaja; Larry L David; Ivan Ahel; Michael S Cohen
Journal:  Cell Rep       Date:  2016-01-07       Impact factor: 9.423

Review 5.  ADP-ribosylation of arginine.

Authors:  Sabrina Laing; Mandy Unger; Friedrich Koch-Nolte; Friedrich Haag
Journal:  Amino Acids       Date:  2010-07-21       Impact factor: 3.520

Review 6.  The macro domain protein family: structure, functions, and their potential therapeutic implications.

Authors:  Weidong Han; Xiaolei Li; Xiaobing Fu
Journal:  Mutat Res       Date:  2011-03-21       Impact factor: 2.433

7.  Proteome-wide identification of poly(ADP-ribose) binding proteins and poly(ADP-ribose)-associated protein complexes.

Authors:  Jean-Philippe Gagné; Maxim Isabelle; Ken Sin Lo; Sylvie Bourassa; Michael J Hendzel; Valina L Dawson; Ted M Dawson; Guy G Poirier
Journal:  Nucleic Acids Res       Date:  2008-11-03       Impact factor: 16.971

8.  Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease.

Authors:  Karim Gariani; Dongryeol Ryu; Keir J Menzies; Hyon-Seung Yi; Sokrates Stein; Hongbo Zhang; Alessia Perino; Vera Lemos; Elena Katsyuba; Pooja Jha; Sandrine Vijgen; Laura Rubbia-Brandt; Yong Kyung Kim; Jung Tae Kim; Koon Soon Kim; Minho Shong; Kristina Schoonjans; Johan Auwerx
Journal:  J Hepatol       Date:  2016-09-20       Impact factor: 25.083

9.  PARP-1 Inhibition Is Neuroprotective in the R6/2 Mouse Model of Huntington's Disease.

Authors:  Antonella Cardinale; Emanuela Paldino; Carmela Giampà; Giorgio Bernardi; Francesca R Fusco
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

10.  Deficiency of terminal ADP-ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative disease.

Authors:  Reza Sharifi; Rosa Morra; C Denise Appel; Michael Tallis; Barry Chioza; Gytis Jankevicius; Michael A Simpson; Ivan Matic; Ege Ozkan; Barbara Golia; Matthew J Schellenberg; Ria Weston; Jason G Williams; Marianna N Rossi; Hamid Galehdari; Juno Krahn; Alexander Wan; Richard C Trembath; Andrew H Crosby; Dragana Ahel; Ron Hay; Andreas G Ladurner; Gyula Timinszky; R Scott Williams; Ivan Ahel
Journal:  EMBO J       Date:  2013-03-12       Impact factor: 11.598

View more
  3 in total

1.  Discovery of an NAD+ analogue with enhanced specificity for PARP1.

Authors:  Xiao-Nan Zhang; Albert T Lam; Qinqin Cheng; Valentine V Courouble; Timothy S Strutzenberg; Jiawei Li; Yiling Wang; Hua Pei; Bangyan L Stiles; Stan G Louie; Patrick R Griffin; Yong Zhang
Journal:  Chem Sci       Date:  2022-01-27       Impact factor: 9.825

Review 2.  Functionalised Cofactor Mimics for Interactome Discovery and Beyond.

Authors:  Isabel V L Wilkinson; Martin Pfanzelt; Stephan A Sieber
Journal:  Angew Chem Int Ed Engl       Date:  2022-05-31       Impact factor: 16.823

Review 3.  Recent advances in activity-based probes (ABPs) and affinity-based probes (AfBPs) for profiling of enzymes.

Authors:  Haixiao Fang; Bo Peng; Sing Yee Ong; Qiong Wu; Lin Li; Shao Q Yao
Journal:  Chem Sci       Date:  2021-05-18       Impact factor: 9.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.